Get startedLog in
    Picture of Shenzhen Hepalink Pharmaceutical Co logo

    9989 — Shenzhen Hepalink Pharmaceutical Co News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Shenzhen Hepalink Pharma's To Sell Asset In Kymab

    Picture of Shenzhen Hepalink Pharmaceutical Co logoShenzhen Hepalink Pharmaceutical Co
    11/01/2021 12:05
    Jan 11 (Reuters) - Shenzhen Hepalink Pharmaceutical
 002399.SZ :
    * SAYS ITS UNIT PLANS TO SELL ASSET IN KYMAB TO SANOFI'S
UNIT FOR
ABOUT $117 MILLION
    * SAYS ITS UNIT COULD RECEIVE UP TO ANOTHER $30.3 MILLION OF
MILESTONE PAYMENT

Source text in Chinese: https://bit.ly/2XscoNh
Further company coverage:  002399.SZ 

 (Reporting by Hong Kong newsroom)
 ((hongkong.newsroom@thomsonreuters.com; （8610）6627-1277;
Reuters Messaging: roxanne.liu@thomsonreuters.com))

    Recent news on Shenzhen Hepalink Pharmaceutical Co

    See all news